000 01167 a2200325 4500
005 20250513195125.0
264 0 _c19991206
008 199912s 0 0 eng d
022 _a0076-6879
024 7 _a10.1016/s0076-6879(99)14123-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aZiegler, A
245 0 0 _aOptimizing efficacy of antisense oligodeoxynucleotides targeting inhibitors of apoptosis.
_h[electronic resource]
260 _bMethods in enzymology
_c2000
300 _a477-90 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aBreast Neoplasms
_xgenetics
650 0 4 _aCarcinoma, Non-Small-Cell Lung
_xgenetics
650 0 4 _aDrug Design
650 0 4 _aHumans
650 0 4 _aLung Neoplasms
650 0 4 _aOligodeoxyribonucleotides, Antisense
_xpharmacology
650 0 4 _aProto-Oncogene Proteins c-bcl-2
_xgenetics
650 0 4 _aTransfection
700 1 _aSimões-Wuest, A P
700 1 _aZangemeister-Wittke, U
773 0 _tMethods in enzymology
_gvol. 314
_gp. 477-90
856 4 0 _uhttps://doi.org/10.1016/s0076-6879(99)14123-5
_zAvailable from publisher's website
999 _c10521316
_d10521316